Sprout2 dba Sprout Pharmaceuticals has filed a notice of an exempt offering of securities to raise $10,000,000.00 in New Debt Financing.
According to filings with the U.S. Securities and Exchange Commission, Sprout2 dba Sprout Pharmaceuticals is raising $10,000,000.00 in new funding. Sources indicate that as part of senior management Chief Financial Officer, Matthew Petzold played a…
